









Markets
/
Stocks
/
nasdaq-bcax
/

Bicara Therapeutics Inc

BCAX

17.270USD

-0.280-1.60%

Close 12/24, 13:00（ET）Quotes delayed by 15 min

943.16MMarket Cap

LossP/E TTM



Bicara Therapeutics Inc

17.270

-0.280-1.60%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Bicara Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q1

FY2023Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-69.81%-29.25M

---25.59M

-92.68%-28.11M

---30.03M

-63.54%-17.22M

---14.59M

---10.53M

Net income from continuing operations

-107.83%-36.33M

---27.39M

-194.58%-36.85M

---20.96M

23.48%-17.48M

---12.51M

---22.84M

Operating gains losses

60.00%24.00K

--19.00K

46.15%19.00K

--15.00K

650.00%15.00K

--13.00K

--2.00K

Other non-cash items

313.24%281.00K

--211.00K

112.31%138.00K

---276.00K

161.54%68.00K

--65.00K

--26.00K

Change in working capital

270.33%3.16M

---1.93M

255.33%5.13M

---11.99M

-18.89%-1.86M

---3.30M

---1.56M

-Change in prepaid expenses

-178.70%-301.00K

--627.00K

1851.49%4.12M

---16.57M

-532.00%-108.00K

---235.00K

--25.00K

-Change in payables and accrued expense

325.46%3.78M

---2.38M

138.75%1.16M

--4.28M

-6.14%-1.68M

---3.00M

---1.58M

Cash from non-recurring investing activities

Cash from operating activities

-69.81%-29.25M

---25.59M

-92.68%-28.11M

---30.03M

-63.54%-17.22M

---14.59M

---10.53M

Investing cash flow

Net cash from continuing investing activities

425.00%42.00K

--0.00

100.00%0.00

--40.00K

-94.67%8.00K

---58.00K

--150.00K

Capital expenditures

425.00%42.00K

--0.00

-100.00%0.00

--40.00K

-94.67%8.00K

--4.00K

--150.00K

Net cash flow from disposal of fixed assets

425.00%42.00K

--0.00

100.00%0.00

--40.00K

-94.67%8.00K

---58.00K

--150.00K

Net cash flow from investment products

---236.08M

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-2951412.50%-236.12M

--0.00

-100.00%0.00

---40.00K

94.67%-8.00K

--58.00K

---150.00K

Financing cash flow

Cash flow from continuous financing activities

-99.87%436.00K

--135.00K

235.77%460.00K

---975.00K

737.39%334.13M

--137.00K

--39.90M

Net cash flow from common stock issuance/repurchase

----

---1.05M

--333.48M

----

Proceeds from stock option exercised by employees

626.67%436.00K

--135.00K

235.77%460.00K

--77.00K

-28.57%60.00K

--137.00K

--84.00K

Net cash flow from other financing activities

-100.00%0.00

----

--596.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-99.87%436.00K

--135.00K

235.77%460.00K

---975.00K

737.39%334.13M

--137.00K

--39.90M

Net cash flow

Beginning cash balance

114.17%436.61M

--462.06M

112.51%489.71M

--520.76M

1259.94%203.85M

--230.44M

--14.99M

Current period cash flow changes

-183.60%-264.93M

---25.46M

-92.09%-27.65M

---31.05M

984.54%316.90M

---14.39M

--29.22M

Ending cash balance

-67.03%171.67M

--436.61M

113.87%462.06M

--489.71M

1077.92%520.76M

--216.05M

--44.21M

Free cash flow

-69.97%-29.29M

---25.59M

-92.63%-28.11M

---30.07M

-61.32%-17.23M

---14.59M

---10.68M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

